Tokyo Tape
Sign in
← Cuc

Half-year report · HY

9158.TEDINET S100X3FV
Period2025-04-01 → 2025-09-30
Filed2025-11-13
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥26.3bn2025-04-01 → 2025-09-30Cons.Revenue IFRS
Revenue¥47.0bn2024-04-01 → 2025-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥21.6bn2024-04-01 → 2024-09-30Cons.Revenue IFRS
Operating income¥1.7bn2025-04-01 → 2025-09-30Cons.Operating profit loss IFRS
Operating income¥3.0bn2024-04-01 → 2024-09-30Cons.Operating profit loss IFRS
Profit before tax¥1.4bn2025-04-01 → 2025-09-30Cons.Profit loss before tax IFRS
Profit before tax¥5.2bn2024-04-01 → 2025-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥3.2bn2024-04-01 → 2024-09-30Cons.Profit loss before tax IFRS
Net income (owners)¥612m2025-04-01 → 2025-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥3.1bn2024-04-01 → 2025-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥2.0bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥566m2025-04-01 → 2025-09-30Cons.Profit loss IFRS
Net income¥2.0bn2024-04-01 → 2024-09-30Cons.Profit loss IFRS
Total assets¥94.1bnat 2025-09-30Cons.Assets IFRS
Total assets¥85.2bnat 2025-03-31Cons.Assets IFRS
Total assets¥70.2bnat 2024-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥63.4bnat 2025-09-30Cons.Liabilities IFRS
Total liabilities¥54.9bnat 2025-03-31Cons.Liabilities IFRS
Net assets / equity¥30.7bnat 2025-09-30Cons.Equity IFRS
Net assets / equity¥30.3bnat 2025-03-31Cons.Equity IFRS
Net assets / equity¥28.5bnat 2024-09-30Cons.Equity IFRS
Net assets / equity¥28.0bnat 2024-03-31vCons.Equity IFRS
Equity (owners)¥30.2bnat 2025-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥29.7bnat 2025-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥27.9bnat 2024-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥13.3bnat 2025-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥7.5bnat 2025-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥13.2bnat 2024-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥8.3bnat 2024-03-31vCons.Cash and cash equivalents IFRS
Operating cash flow¥2.4bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥2.5bn2024-04-01 → 2025-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥1.9bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥3.4bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow¥4.5bn2024-04-01 → 2025-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥2.0bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow¥6.9bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥7.6bn2024-04-01 → 2025-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥5.1bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥20.892025-04-01 → 2025-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥106.812024-04-01 → 2025-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥68.512024-04-01 → 2024-09-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥20.892025-04-01 → 2025-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥106.812024-04-01 → 2025-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥68.512024-04-01 → 2024-09-30Cons.Diluted earnings loss per share IFRS
Equity ratio32.0%at 2025-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio34.8%at 2025-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio39.8%at 2024-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 52
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2025-04-01 → 2025-09-30¥41m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2025-04-01 → 2025-09-30¥41m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2025-04-01 → 2025-09-30−¥10m
Reconciling Itemsreconcilingrevenue2025-04-01 → 2025-09-30−¥226m
Reconciling Itemsreconcilingrevenue intersegment2025-04-01 → 2025-09-30−¥226m
Reconciling Itemsreconcilingsegment profit2025-04-01 → 2025-09-30−¥454m
Hospicereportable segmentrevenue2025-04-01 → 2025-09-30¥7.9bn
Hospicereportable segmentrevenue external2025-04-01 → 2025-09-30¥7.9bn
Hospicereportable segmentsegment profit2025-04-01 → 2025-09-30¥139m
In Home Nursingreportable segmentrevenue2025-04-01 → 2025-09-30¥6.5bn
In Home Nursingreportable segmentrevenue external2025-04-01 → 2025-09-30¥6.5bn
In Home Nursingreportable segmentrevenue intersegment2025-04-01 → 2025-09-30¥3m
In Home Nursingreportable segmentsegment profit2025-04-01 → 2025-09-30¥657m
Management Supportreportable segmentrevenue2025-04-01 → 2025-09-30¥8.2bn
Management Supportreportable segmentrevenue external2025-04-01 → 2025-09-30¥8.0bn
Management Supportreportable segmentrevenue intersegment2025-04-01 → 2025-09-30¥223m
Management Supportreportable segmentsegment profit2025-04-01 → 2025-09-30¥1.5bn
Medical Care Residencereportable segmentrevenue2025-04-01 → 2025-09-30¥3.8bn
Medical Care Residencereportable segmentrevenue external2025-04-01 → 2025-09-30¥3.8bn
Medical Care Residencereportable segmentsegment profit2025-04-01 → 2025-09-30−¥96m
—segment totalrevenue2025-04-01 → 2025-09-30¥26.5bn
—segment totalrevenue external2025-04-01 → 2025-09-30¥26.3bn
—segment totalrevenue intersegment2025-04-01 → 2025-09-30¥226m
—segment totalsegment profit2025-04-01 → 2025-09-30¥2.2bn
Total Of Reportable Segments And Otherssegment totalrevenue2025-04-01 → 2025-09-30¥26.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2025-04-01 → 2025-09-30¥26.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2025-04-01 → 2025-09-30¥226m
Total Of Reportable Segments And Otherssegment totalsegment profit2025-04-01 → 2025-09-30¥2.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-04-01 → 2024-09-30¥83m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-04-01 → 2024-09-30¥83m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-04-01 → 2024-09-30¥55m
Reconciling Itemsreconcilingrevenue2024-04-01 → 2024-09-30−¥157m
Reconciling Itemsreconcilingrevenue intersegment2024-04-01 → 2024-09-30−¥157m
Reconciling Itemsreconcilingsegment profit2024-04-01 → 2024-09-30−¥439m
Hospicereportable segmentrevenue2024-04-01 → 2024-09-30¥6.7bn
Hospicereportable segmentrevenue external2024-04-01 → 2024-09-30¥6.7bn
Hospicereportable segmentsegment profit2024-04-01 → 2024-09-30¥690m
In Home Nursingreportable segmentrevenue2024-04-01 → 2024-09-30¥6.1bn
In Home Nursingreportable segmentrevenue external2024-04-01 → 2024-09-30¥6.1bn
In Home Nursingreportable segmentsegment profit2024-04-01 → 2024-09-30¥540m
Management Supportreportable segmentrevenue2024-04-01 → 2024-09-30¥8.9bn
Management Supportreportable segmentrevenue external2024-04-01 → 2024-09-30¥8.7bn
Management Supportreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥157m
Management Supportreportable segmentsegment profit2024-04-01 → 2024-09-30¥2.2bn
—segment totalrevenue2024-04-01 → 2024-09-30¥21.7bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥21.5bn
—segment totalrevenue intersegment2024-04-01 → 2024-09-30¥157m
—segment totalsegment profit2024-04-01 → 2024-09-30¥3.4bn
Total Of Reportable Segments And Otherssegment totalrevenue2024-04-01 → 2024-09-30¥21.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-04-01 → 2024-09-30¥21.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2024-04-01 → 2024-09-30¥157m
Total Of Reportable Segments And Otherssegment totalsegment profit2024-04-01 → 2024-09-30¥3.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 851
ItemContextValueUnit
Finance income IFRSInterimDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember－JPY
Finance income IFRSInterimDuration_TotalOfReportableSegmentsAndOthersMember－JPY
Finance income IFRSInterimDuration_ReconcilingItemsMember－JPY
Finance income IFRSInterimDuration23000000JPY
Finance costs IFRSInterimDuration_jpcrp040300-ssr_E37214-000ManagementSupportReportableSegmentMember－JPY
Finance costs IFRSInterimDuration_jpcrp040300-ssr_E37214-000HospiceReportableSegmentMember－JPY
Finance costs IFRSInterimDuration_jpcrp040300-ssr_E37214-000InHomeNursingReportableSegmentMember－JPY
Finance costs IFRSInterimDuration_jpcrp040300-ssr_E37214-000MedicalCareResidenceReportableSegmentMember－JPY
Finance costs IFRSInterimDuration_ReportableSegmentsMember－JPY
Finance costs IFRSInterimDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember－JPY
Finance costs IFRSInterimDuration_TotalOfReportableSegmentsAndOthersMember－JPY
Finance costs IFRSInterimDuration_ReconcilingItemsMember－JPY
Finance costs IFRSInterimDuration337000000JPY
Profit loss before tax IFRSInterimDuration_jpcrp040300-ssr_E37214-000ManagementSupportReportableSegmentMember－JPY
Profit loss before tax IFRSInterimDuration_jpcrp040300-ssr_E37214-000HospiceReportableSegmentMember－JPY
Profit loss before tax IFRSInterimDuration_jpcrp040300-ssr_E37214-000InHomeNursingReportableSegmentMember－JPY
Profit loss before tax IFRSInterimDuration_jpcrp040300-ssr_E37214-000MedicalCareResidenceReportableSegmentMember－JPY
Profit loss before tax IFRSInterimDuration_ReportableSegmentsMember－JPY
Profit loss before tax IFRSInterimDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember－JPY
Profit loss before tax IFRSInterimDuration_TotalOfReportableSegmentsAndOthersMember－JPY
Profit loss before tax IFRSInterimDuration_ReconcilingItemsMember－JPY
Profit loss before tax IFRSInterimDuration1397000000JPY
Profit loss IFRSInterimDuration_jpcrp040300-ssr_E37214-000ManagementSupportReportableSegmentMember－JPY
Profit loss IFRSInterimDuration_jpcrp040300-ssr_E37214-000HospiceReportableSegmentMember－JPY
Profit loss IFRSInterimDuration_jpcrp040300-ssr_E37214-000InHomeNursingReportableSegmentMember－JPY
Profit loss IFRSInterimDuration_jpcrp040300-ssr_E37214-000MedicalCareResidenceReportableSegmentMember－JPY
Profit loss IFRSInterimDuration_ReportableSegmentsMember－JPY
Profit loss IFRSInterimDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember－JPY
Profit loss IFRSInterimDuration_TotalOfReportableSegmentsAndOthersMember－JPY
Profit loss IFRSInterimDuration_ReconcilingItemsMember－JPY
Profit loss IFRSInterimDuration566000000JPY
Depreciation and amortization operating expenses IFRSInterimDuration_jpcrp040300-ssr_E37214-000ManagementSupportReportableSegmentMember542000000JPY
Depreciation and amortization operating expenses IFRSInterimDuration_jpcrp040300-ssr_E37214-000HospiceReportableSegmentMember701000000JPY
Depreciation and amortization operating expenses IFRSInterimDuration_jpcrp040300-ssr_E37214-000InHomeNursingReportableSegmentMember257000000JPY
Depreciation and amortization operating expenses IFRSInterimDuration_jpcrp040300-ssr_E37214-000MedicalCareResidenceReportableSegmentMember822000000JPY
Depreciation and amortization operating expenses IFRSInterimDuration_ReportableSegmentsMember2322000000JPY
Depreciation and amortization operating expenses IFRSInterimDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember4000000JPY
Depreciation and amortization operating expenses IFRSInterimDuration_TotalOfReportableSegmentsAndOthersMember2326000000JPY
Depreciation and amortization operating expenses IFRSInterimDuration_ReconcilingItemsMember－JPY
Depreciation and amortization operating expenses IFRSInterimDuration2326000000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2025-11-13
Semi annual accounting period cover pageFilingDateInstant
Original text (Japanese)第12期中（自　2025年４月１日　至　2025年９月30日）
Company name cover pageFilingDateInstant
Original text (Japanese)株式会社シーユーシー
Company name in english cover pageFilingDateInstantCUC Inc.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役　　濵口　慶太
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都港区芝浦三丁目１番１号
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)03（5005）0808（代表）

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2025-03-31pass
balance sheet identityconsolidated 2025-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2025-04-01/2025-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2025-04-01/2025-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2025-04-01/2025-09-30pass
statement vs summary · total assetsconsolidated 2025-03-31pass
statement vs summary · total assetsconsolidated 2025-09-30pass